Neural Analytics, the Los Angeles based company that won FDA clearance a couple of years ago for its Lucid M1 Transcranial Doppler Ultrasound System, now won another clearance, this time for its NeuralBot robotic ultrasound positioner. The two devices work together and when united will be called the Lucid Robotic System.
The NeuralBot automatically positions the ultrasound probe,...
Zemdri (plazomicin) Approved by FDA for the Treatment of Adults with Complicated Urinary Tract Infections (cUTI)
Achaogen, Inc., a biopharmaceutical company developing and commercializing innovative antibacterial agents to address multidrug resistant (MDR) gram-negative infections, announced that the U.S. Food and Drug Administration (FDA) has approved Zemdri (plazomicin) for adults with complic...
Kratom shares structural similarities with opioid analgesics
Opioid-like dependence due to chronic kratom use can be successfully treated with buprenorphine, according to a recent case report published in the Journal of Addiction Medicine.
Kratom, an herbal supplement that shares structural similarities with opioid analgesics, has recently grown in popularity in the West ...
Amgen announced that the results of two open-label extension (OLE) studies of AimovigTM (erenumab-aooe) in patients with chronic and episodic migraine, respectively, will be presented at the 60th Annual Scientific Meeting of the American Headache Society (AHS) in San Francisco. Results from a one-year study in chronic migraine patients reinforced the established safety and efficacy profile of Aimo...